文献速递慢性肾脏病肾移植

一种改进的肾单位数量估算方法及估算结果与慢性肾脏病结局的关联

An Improved Method for Estimating Nephron Number and the Association of Resulting Nephron Number Estimates with Chronic Kidney Disease Outcomes.
PubMed 文献 · J Am Soc Nephrol · 2023-03-23

研究纳入3020例活体肾捐献者和1354例因肿瘤行根治性肾切除术的患者,基于肾活检肾小球密度与影像学皮质体积估算肾单位数量,并对缺失肾小球簇、肾被膜缺失及组织收缩等偏倚进行校正。校正后供肾估算值较旧方法高27%,肿瘤患者高1%;低肾单位数量独立预测两人群的CKD结局。

要点

  • 新方法校正多种测量偏倚后,供肾肾单位估算值较旧方法高27%,肿瘤患者高1%。
  • 供者每肾约1.17百万个肾单位,肿瘤患者每肾约0.99百万个肾单位。
  • 校正临床特征后,低肾单位数量独立预测两人群的CKD结局。

核心结论

  • 与旧方法相比,新方法校正多种偏倚后估算的肾单位数量在供者中高27%、在肿瘤患者中高1%,且两群体间表现一致。
  • 低肾单位数量在两群体中均独立预测CKD。

研究设计与样本

  • 研究纳入3020例活体肾捐献者和1354例因肿瘤行根治性肾切除术的患者。
  • 通过术前影像确定保留肾的皮质体积,并对捐献肾穿刺活检标本和切除肾楔形切片进行形态计量分析以确定肾小球密度。
  • 基于30例尸检肾分析,对肾小球密度校正缺失肾小球簇、肾被膜缺失及组织收缩。
  • 在供者中使用逻辑回归、在肿瘤患者中使用Cox比例风险模型评估肾单位数量相关的CKD结局风险。

主要发现

  • 供者每肾有1.17百万个肾单位,肿瘤患者每肾有0.99百万个肾单位。
  • 较低的肾单位数量与年龄较大、女性、身高较矮、高血压、ESKD家族史、较低GFR和蛋白尿相关。
  • 校正上述特征后,供者与肿瘤患者的肾单位数量无差异。
  • 以健康亚组按年龄和性别定义的<5th或<10th百分位判定低肾单位数量,两群体中低肾单位数量均独立于活检和临床特征预测未来CKD结局风险。

关键数值与推荐

  • 低肾单位数量定义为健康亚组中按年龄和性别分布的<5th或<10th百分位。
  • 新方法估算的肾单位数量较旧方法在供者中高27%、在肿瘤患者中高1%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: Nephron number currently can be estimated only from glomerular density on a kidney biopsy combined with cortical volume from kidney imaging. Because of measurement biases, refinement of this approach and validation across different patient populations have been needed. The prognostic importance of nephron number also has been unclear. The authors present an improved method of estimating nephron number that corrects for several biases, resulting in a 27% higher nephron number estimate for donor kidneys compared with a prior method. After accounting for comorbidities, the new nephron number estimate does not differ between kidney donors and kidney patients with tumor and shows consistent associations with clinical characteristics across these two populations. The findings also indicate that low nephron number predicts CKD independent of biopsy and clinical characteristics in both populations. BACKGROUND: Nephron number can be estimated from glomerular density and cortical volume. However, because of measurement biases, this approach needs refinement, comparison between disparate populations, and evaluation as a predictor of CKD outcomes. METHODS: We studied 3020 living kidney donors and 1354 patients who underwent radical nephrectomy for tumor. We determined cortex volume of the retained kidney from presurgical imaging and glomerular density by morphometric analysis of needle core biopsy of the donated kidney and wedge sections of the removed kidney. Glomerular density was corrected for missing glomerular tufts, absence of the kidney capsule, and then tissue shrinkage on the basis of analysis of 30 autopsy kidneys. We used logistic regression (in donors) and Cox proportional hazard models (in patients with tumor) to assess the risk of CKD outcomes associated with nephron number. RESULTS: Donors had 1.17 million nephrons per kidney; patients with tumor had 0.99 million nephrons per kidney. A lower nephron number was associated with older age, female sex, shorter height, hypertension, family history of ESKD, lower GFR, and proteinuria. After adjusting for these characteristics, nephron number did not differ between donors and patients with tumor. Low nephron number (defined by <5th or <10th percentile by age and sex in a healthy subset) in both populations predicted future risk of CKD outcomes independent of biopsy and clinical characteristics. CONCLUSIONS: Compared with an older method for estimating nephron number, a new method that addresses several sources of bias results in nephron number estimates that are 27% higher in donors and 1% higher in patients with tumor and shows consistency between two populations. Low nephron number independently predicts CKD in both populations.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Denic A, Mullan AF, Alexander MP, et al. An Improved Method for Estimating Nephron Number and the Association of Resulting Nephron Number Estimates with Chronic Kidney Disease Outcomes. J Am Soc Nephrol. 2023. PMID: 36958059. doi:10.1681/ASN.0000000000000124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。